<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref125">
 <mixed-citation publication-type="journal" id="cit125">
  <name>
   <surname>Dyall</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Coleman</surname>
   <given-names>C. M.</given-names>
  </name>; 
  <name>
   <surname>Hart</surname>
   <given-names>B. J.</given-names>
  </name>; 
  <name>
   <surname>Venkataraman</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Holbrook</surname>
   <given-names>M. R.</given-names>
  </name>; 
  <name>
   <surname>Kindrachuk</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Johnson</surname>
   <given-names>R. F.</given-names>
  </name>; 
  <name>
   <surname>Olinger</surname>
   <given-names>G. G.</given-names>
  </name>; 
  <name>
   <surname>Jahrling</surname>
   <given-names>P. B.</given-names>
  </name>; 
  <name>
   <surname>Laidlaw</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Johansen</surname>
   <given-names>L. M.</given-names>
  </name>; 
  <name>
   <surname>Lear-Rooney</surname>
   <given-names>C. M.</given-names>
  </name>; 
  <name>
   <surname>Glass</surname>
   <given-names>P. J.</given-names>
  </name>; 
  <name>
   <surname>Hensley</surname>
   <given-names>L. E.</given-names>
  </name>; 
  <name>
   <surname>Frieman</surname>
   <given-names>M. B.</given-names>
  </name>
  <article-title>Repurposing of clinically developed drugs for treatment of middle east respiratory syndrome coronavirus infection</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <year>2014</year>, 
  <volume>58</volume>, 
  <fpage>4885</fpage>â€“
  <lpage>4893</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.03036-14</pub-id>.
  <pub-id pub-id-type="pmid">24841273</pub-id>
 </mixed-citation>
</ref>
